<unk>  has not been adequately studied for the treatment of children as well as pregnant and lactating women. The drug is given to these groups only if a risk-benefit analysis is positive.
Octreotide
Edotreotide
Lanreotide
Fertirelin
Metoclopramide
Tenatoprazole
Leuprorelin
Rabeprazole